EXCERPT

> IBM is busy applying its Watson AI to as many health arenas as possible and it looks like cancer genomic sequencing could be its next big market.
>
> In a new proof-of-concept study testing a beta version of its genomic sequencing-specific version of Watson, Watson for Genomics, IBM's AI has once again shown potential.

Source: https://pharmaphorum.com/news/watson-for-genomics-brain-tumour/

Full article: http://ng.neurology.org/content/3/4/e164.full